Skip to search boxSkip to navigationSkip to main content

Gender differences in host defense mechanisms

  • Joseph G. Cannon(corresponding author)
    ,
  • Barbara A. St. Pierre
*Corresponding author for this work
  • Pennsylvania State University
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Extensive studies in both humans and animals have shown that females express enhanced levels of immunoreactivity compared to males. Whereas this provides females with increased resistance to many types of infection, it also makes them more susceptible to autoimmune diseases. This review will focus on gender-related differences in non-specific host defense mechanisms with a particular emphasis on monocyte/macrophage function and a primary product of monocytes: interleukin-1 (IL-1). Immunomodulatory cytokines such as IL-1 are influenced by gender-sensitive hormones, and reciprocally, these cytokines influence gender-specific hormones and tissues. Patients with chronic fatigue syndrome (CFS) are predominantly women, therefore it may be useful to look toward gender-specific differences in immune function to find a key for this poorly understood syndrome.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 99-113 (15 pages)

Journal (Volume, Issue Number)

Journal of Psychiatric Research (Volume 31, Issue 1)

Publication milestones

  • Published - 01/1997

Publication status

Published - 01/1997

ISSN

0022-3956

Publication IDs

  • Scopus: 0030906644
  • PubMed: 9201652

Publication metrics

Metrics

SciVal
citations
78
SciVal
FWCI
2.93
SciVal
Author count
2
SciVal
Paper percentile
92
SciVal
Top percentile
10
Scopus
citations
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
27
Usage
93
Citation count
89

Funding Details

FunderFunding number
NIAID
R01AI033414